Menu
Search icon
  1. Home Page
    2. ›
  2. Counties
    3. ›
  3. New York
    4. ›
  4. 10027
    5. ›
  5. QUICKSILVER BIOSCIENCES, INC.

QUICKSILVER BIOSCIENCES, INC.

Company Details

Name: QUICKSILVER BIOSCIENCES, INC.
Jurisdiction: New York
Legal type: FOREIGN BUSINESS CORPORATION
Status: Active
Date of registration: 12 Jun 2020 (5 years ago)
Entity Number: 5766384
ZIP code: 10027
County: New York
Place of Formation: Delaware
Address: 1361 AMSTERDAM AVE, SUITE 340, NEW YORK, NY, United States, 10027
Principal Address: 1361 Amsterdam Avenue, Suite 340, New York, NY, United States, 10027

DOS Process Agent

Name Role Address
THE CORPORATION DOS Process Agent 1361 AMSTERDAM AVE, SUITE 340, NEW YORK, NY, United States, 10027

Chief Executive Officer

Name Role Address
ERIK YOUNG Chief Executive Officer 1361 AMSTERDAM AVE, SUITE 340, NEW YORK, NY, United States, 10027

U.S. Small Business Administration Profile

The U.S. Small Business Administration (SBA) helps Americans start, grow, and build resilient businesses.

Note: SBA was created in 1953 as an independent agency of the federal government to aid, counsel, assist and protect the interests of small business concerns; preserve free competitive enterprise; and maintain and strengthen the overall economy of our nation. SBA reviews Congressional and testifies on behalf of small businesses. It assesses the impact of regulatory burden on small businesses.

E-Commerce Website:
http://www.quicksilverbiosciences.com
Phone Number:
914-643-8717
E-mail Address:
shepard@quicksilverbiosciences.com
Contact Person:
KENNETH SHEPARD
User ID:
P2310013

Form 5500 Series

Employer Identification Number (EIN):
825358567
Plan Year:
2023
Number Of Participants:
3
Sponsors Telephone Number:
9173341824
File:
View File
Plan Year:
2021
Number Of Participants:
3
Sponsors Telephone Number:
9173341824
File:
View File
Plan Year:
2020
Number Of Participants:
3
Sponsors Telephone Number:
9173341824
File:
View File
Plan Year:
2019
Number Of Participants:
0
File:
View File

Filings

Filing Number Date Filed Type Effective Date
220705003080 2022-07-05 BIENNIAL STATEMENT 2022-06-01
200612000048 2020-06-12 APPLICATION OF AUTHORITY 2020-06-12

USAspending Awards / Financial Assistance

Date:
2021-03-15
Link:
View on USAspending
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
DIRECT BIOELECTRONIC DETECTION OF SARS-COV-2 FROM SALIVA USING SINGLE-MOLECULE FIELD-EFFECT TRANSISTOR ARRAY - DIRECT BIOELECTRONIC DETECTION OF SARS-COV-2 FROM SALIVA USING SINGLE-MOLECULE FIELD-EFFECT TRANSISTOR ARRAY NUCLEIC ACID TESTS HAVE BECOME THE GOLD-STANDARD FOR DIAGNOSTIC TESTING FOR COVID-19, USUALLY PERFORMED IN SPECIALIZED LABORATORIES. MOST ARE BASED ON REVERSE-TRANSCRIPTION QUANTITATIVE POLYMERASE CHAIN REACTION (QRT-PCR). THE TIME REQUIRED FOR SPECIMEN TRANSPORT AND PROCESSING RESULTS IN A TURNAROUND TIME THAT IS TYPI- CALLY SEVERAL DAYS. THE FEW RAPID (<1 HOUR) POINT-OF-CARE (POC) TESTS ARE MORE EXPENSIVE, STILL REQUIRE SAMPLE PREPARATION AND SPECIALIZED REAGENTS, AND DO NOT HAVE THE THROUGHPUT NEEDED FOR POPULATION SURVEILLANCE. DI- RECT TESTING FOR THE VIRUS, WHICH ALSO REDUCES REQUIREMENTS FOR MULTIPLE REAGENTS, IS A NECESSARY STEP TO IMPROV- ING DIAGNOSTIC TESTING. WHILE FOUR SUCH ANTIGEN TESTS HAVE BEEN APPROVED FOR DETECTION OF SARS-COV-2 BASED ON IMMUNOASSAYS TO THE N PROTEIN, SENSITIVITY IS LIMITED AND NO QUANTITATION OF VIRAL LOAD IS POSSIBLE. WE WILL ADDRESS THIS GAP BY USING DIAGNOSTIKOSTM, AN IN-DEVELOPMENT RAPID POC PLATFORM FOR DIRECT, REAL- TIME, MULTIPLEXED, QUANTITATIVE BIOELECTRONIC DETECTION OF BIOMOLECULES THAT EMPLOYS AN ALL-ELECTRONIC DETECTION DEVICE THAT FUNCTIONS AT THE SINGLE-MOLECULE LEVEL. THESE SINGLE-MOLECULE FIELD-EFFECT TRANSISTORS (SMFETS) ARE ARRAYED ON A COMPLEMENTARY METAL-OXIDE-SEMICONDUCTOR (CMOS) INTEGRATED CIRCUIT CHIP. CHIPS WILL INTERFACE WITH AN ENVISIONED USB-STICK-FORM-FACTOR READER DEVICE. ROBUST SINGLE-DOMAIN ANTIBODIES, KNOWN AS NANOBOD- IES AND IMMOBILIZED ON THESE DEVICES, ARE USED FOR SENSITIVE DETECTION OF VIRAL PARTICLES AND VIRAL DEBRIS. THE USE OF MULTIPLE NANOBODIES FOR A SINGLE PROTEIN AND NANOBODIES FOR DIFFERENT PROTEINS IN A SINGLE ASSAY ALLOWS FOR SIGNIFICANT IMPROVEMENTS IN SPECIFICITY. NANOBODIES WILL BE SPECIFIC FOR ONE OR MORE OF THE FOUR MAJOR STRUC- TURAL PROTEINS IN SARS-COV-2; THE NUCLEOCAPSID (N) PROTEIN ENGULFING THE VIRAL RNA, THE SPIKE (S) PROTEIN, THE MEMBRANE (M) PROTEIN AND THE ENVELOPE (E) PROTEIN. NO SAMPLE PREPARATION OR SPECIALIZED REAGENTS ARE RE- QUIRED FOR DETECTION, AND THE DEVICE WILL BE DESIGNED TO OPERATE WITH SALIVA, WHICH HAS VERY RECENTLY BEEN SHOWN TO BE A RELIABLE MEDIUM FOR DETECTING SARS-COV-2. INDIVIDUAL SENSOR CHIPS CAN BE MANUFACTURED AT A COST OF $35. WITH THE ADDITION OF OTHER NANOBODIES, THESE LARGE DENSE ARRAYS CAN ALSO ALLOW DETECTION OF MANY PATHOGENS IN A SINGLE TEST. IN THIS DIRECT-TO-PHASE-2 SBIR PROGRAM WE WILL PURSUE SEVERAL KEY INNOVATIONS THAT ARE REQUIRED TO MAKE SUCH A PLATFORM POSSIBLE, INCLUDING ISOLATION OF NANOBODIES FOR KEY STRUCTURE PROTEINS OF SARS-COV-2 (SPECIFIC AIM 1), DEVELOPMENT OF THE SMFET PLATFORM FOR ANTIGEN DETECTION (SPECIFIC AIM 2), DEVELOPMENT OF LARGE CMOS ARRAYS OF THESE SMFET DEVICES (SPECIFIC AIM 3), AND VERIFICATION OF DETECTION IN INCREASINGLY COMPLEX SAMPLES UP TO AND INCLUDING CLINICAL SAMPLES (SPECIFIC AIM 4). THIS PROJECT IS A PARTNERSHIP BETWEEN UNIVERSITY RESEARCHERS WHO DEVELOPED THE SMFET TECHNOLOGY AND A VENTURE-BASED START-UP VENTURE, QUICKSILVER BIOSCI- ENCES, SPUN OUT TO COMMERCIALIZE SMFET TECHNOLOGY AND DEVELOP SMFET/CMOS ARRAYS FOR MOLECULAR DIAG- NOSTIC APPLICATIONS.
Obligated Amount:
1265136.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2020-09-01
Link:
View on USAspending
Awarding Agency Name:
National Science Foundation
Transaction Description:
SBIR PHASE I: RAPID COVID-19 DIAGNOSTICS WITH CMOS-INTEGRATED SINGLE-MOLECULE FIELD-EFFECT TRANSISTORS
Obligated Amount:
255678.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2020-04-29
Link:
View on USAspending
Awarding Agency Name:
Small Business Administration
Transaction Description:
TO AID SMALL BUSINESSES IN MAINTAINING WORK FORCE DURING COVID-19 PANDEMIC.
Obligated Amount:
0.00
Face Value Of Loan:
22477.00
Total Face Value Of Loan:
22477.00
Date:
2019-02-15
Link:
View on USAspending
Awarding Agency Name:
National Science Foundation
Transaction Description:
SBIR PHASE I: SINGLE-MOLECULE FIELD-EFFECT TRANSISTOR ARRAYS FOR MULTIPLEXED GENOMIC IDENTIFICATION OF INFECTIOUS DISEASES
Obligated Amount:
225000.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00

Trademarks Section

Serial Number:
88877826
Mark:
DIAGNOSTIKOS
Status:
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
Mark Type:
TRADEMARK
Application Filing Date:
2020-04-18
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
DIAGNOSTIKOS
USPTO Link:
View Trademark Status and Document Retrieval (TSDR)

Goods And Services

For:
Medical diagnostic apparatus for testing DNA and RNA samples
International Classes:
010 - Primary Class
Class Status:
Active

Paycheck Protection Program

Date Approved:
2020-04-29
Loan Status:
Paid in Full
SBA Guaranty Percentage:
100
Initial Approval Amount:
22477
Current Approval Amount:
22477
Race:
Unanswered
Ethnicity:
Unknown/NotStated
Gender:
Unanswered
Veteran:
Unanswered
Forgiveness Amount:
22706.14

Related by officers

THE CORPORATION

ARSHIA DESIGNS INC. AAA VACUUM CORP. ATLANTICA TELECOM, INC. MISTY SPORTSWEAR, INC. FAT JAMS ELECTRONICS INC. CROQUEMBOUCHE, INC. LONG BEACH PEDIATRIC GROUP, P.C. LAW OFFICES OF JOSEPH A. GRECO, P.C. TEREZ, INC. 732 CINNAMON BEACH INC.

ERIK YOUNG

PCL SOLUTIONS, LLC

Related by address

No related companies by address

Date of last update: 22 Mar 2025

Sources: New York Secretary of State

Privacy policy Policy
About us About us
Contacts Contact us

© 2025 bizyork.com, Part of Big Data Integrated